Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call Prepared Remarks Transcript

Core Viewpoint - Emergent BioSolutions, Inc. is discussing its operational and financial results for Q4 and the full year of 2025 during the earnings conference call [2]. Group 1: Financial Performance - The earnings call will cover both operational and financial results for the fourth quarter and the entire year of 2025 [2]. - The company may discuss non-GAAP financial measures to provide greater transparency regarding its operating performance [4]. Group 2: Forward-Looking Statements - Emergent may make projections and forward-looking statements related to its business and future performance, which are based on current intentions and beliefs [3]. - Any forward-looking statement is only valid as of the date of the conference call, and the company does not commit to updating these statements unless required by law [3].